Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | GLS | O94925 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6865245 | 0.92 | CYP2C19 (0.41) | CYP2C19LMNAKDM4EALDH1A1GLA | |
| SCHEMBL6865241 | 0.82 | ALDH1A1 (0.42) | CYP2C19LMNAKDM4EALDH1A1GLA | |
| SCHEMBL6865247 | 0.82 | ALDH1A1 (0.42) | CYP2C19LMNAKDM4EALDH1A1GLA | |
| SCHEMBL348053 | 0.80 | ALDH1A1 (0.57) | LMNAKDM4EALDH1A1GLAGLS | |
| SCHEMBL3769408 | 0.79 | KMT2A (0.58) | CYP2C19LMNAKDM4EALDH1A1CYP1A2 | |
| SCHEMBL3322508 | 0.78 | LMNA (0.61) | CYP2C19LMNAKDM4EALDH1A1GLA | |
| SCHEMBL6863522 | 0.71 | ALDH1A1 (0.47) | LMNAKDM4EALDH1A1GLAGLS | |
| SCHEMBL18157935 | 0.71 | ALDH1A1 (0.55) | LMNAKDM4EALDH1A1GLAGLS | |
| SCHEMBL6859139 | 0.70 | ALDH1A1 (0.46) | LMNAKDM4EALDH1A1GLAGLS | |
| SCHEMBL10277637 | 0.70 | ALDH1A1 (0.46) | LMNAKDM4EALDH1A1GLAGLS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10622719-B2 | Antenna device and portable terminal comprising same | SKC CO., LTD. (KR) | 2020-04-14 | — | — | US | disclosed |
| US-10593452-B2 | Magnetic sheet and antenna device comprising same | SKC CO., LTD. (KR) | 2020-03-17 | — | — | US | disclosed |
| US-10479050-B2 | Method of preparing conductive magnetic composite sheet and antenna device | SKC CO., LTD. (KR) | 2019-11-19 | — | — | US | disclosed |
| US-20170341341-A1 | METHOD OF PREPARING CONDUCTIVE MAGNETIC COMPOSITE SHEET AND ANTENNA DEVICE | SKC CO., LTD. (KR) | 2017-11-30 | — | — | US | disclosed |
| US-20170346165-A1 | ANTENNA DEVICE AND PORTABLE TERMINAL COMPRISING SAME | SKC CO., LTD. (KR) | 2017-11-30 | — | — | US | disclosed |
| US-20170345535-A1 | MAGNETIC SHEET AND ANTENNA DEVICE COMPRISING SAME | SKC CO., LTD. (KR) | 2017-11-30 | — | — | US | disclosed |
| US-8993775-B2 | Chromium and nickel catalysts for oligomerization reactions and process for obtaining alpha-olefins using said catalysts | Petroleo Brasileiro S.A.—Petrobras (BR) | 2015-03-31 | — | — | US | disclosed |
| US-20120178939-A1 | Chromium and nickel catalysts for oligomerization recations and process for obtaining alpha-olefins using said catalysts | UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL - UFRGS (BR) | 2012-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178939-A1 | Chromium and nickel catalysts for oligomerization recations and process for obtaining alpha-olefins using said catalysts | PCNA, ORC3, AOC3 | CYP2C19 2793/4885LMNA 1308/4885KDM4E 4417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.